TITLE

Eosinophilia in Primary Biliary Cirrhosis

AUTHOR(S)
Yamazaki, Kiyoshi; Nakadate, Ichiro; Suzuki, Kazuyuki; Sato, Shunichi; Masuda, Tomoyuki
PUB. DATE
March 1996
SOURCE
American Journal of Gastroenterology (Springer Nature);Mar1996, Vol. 91 Issue 3, p516
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Recent studies have shown the occurrence of eosinophilia in patients with primary biliary cirrhosis (PBC). To examine whether eosinophilia is indeed a distinctive feature of PBC. we performed extensive leukocyte differential analysis using a highly sophisticated hermatology instrument. We also investigated the relationship between eosinophil dynamics and clinical features of PBC including the effects of ursodeoxycholic acid (UDCA) treatment. Methods: A flow cytometry-based blood cell analyzer (Technicon H6000) was used to examine peripheral hlood eosinophil counts in 38 patients with PBC and 131 patients with various liver diseases. We also performed eosinophil quantitation in 19 PBC patients before and after administration of UDCA for 4 wk. Results: Patients with PBC had significantly higher relative and absolute eosinophil counts when compared with other liver diseases (5.7 ± 0.5% [p < 0.0001. mean ± SEM) and 312 ± 26 cells/µl [p < 0.01], respectively). Twenty-one of 38 PBC patients (55%) exhihited relative eosinophilia. In patients with PBC, the eosinophil count was: 1) significantly higher in those with early histological stages (stage I-II. 6.5 ± 0.5% vs stage III-IV. 4.4 ± 0.7%, p < 0.05). 2) positively correlated with basophil count (p < 0.01). serum IgA levels (p < 0.05). and the degree of eosinophil infiltralion in the portal tract (p < 0.01). and 3) markedly reduced by UDCA treatment (before: 5.9 ± 0.7%, 307 ± 37 cells/µl; after: 2.8 ± 0.3% [p < 0.001], 162 ± 26 cells/µl [p < 0.001]). Conclusions: Eosinophilia is a common and distinctive feature of patients with PBC. UDCA amelio-rates eosinophilia as well as liver function tests in PBC patients, Eosinophilia may be useful as one of the initial clues in the diagnosis of PBC, especially in its early stage.
ACCESSION #
16063228

 

Related Articles

  • New weapon for primary biliary cirrhosis from Japan. Zeniya, Mikio // Journal of Gastroenterology;2003, Vol. 38 Issue 6, p619 

    Editorial. Studies the use of ursodeoxycholic acid (UDCA) for treating patients with primary biliary cirrhosis in Japan. Symptoms of the disease; Immunological properties of UDCA.

  • Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial Papatheodoridis, George V.; Hadziyannis, Emilia S.; Deutsch, Melanie; Hadziyannis, Stephanos J. // American Journal of Gastroenterology;Aug2002, Vol. 97 Issue 8, p2063 

    OBJECTIVES:The aim of this study was to evaluate whether ursodeoxycholic acid (UDCA) has any effect on the development of liver decompensation and on survival of patients with primary biliary cirrhosis (PBC).METHODS:A total of 86 patients with compensated PBC were randomly assigned to receive...

  • Eosinophilic Sclerosing Cholangitis Associated with Hypereosinophilic Syndrome. Grauer, Leopoldo; Padilla, Victor M.; Bouza, Lazaro; Barkin, Jamie S. // American Journal of Gastroenterology;Oct1993, Vol. 88 Issue 10, p1764 

    We describe the case of a 41-yr-old man who presented with signs and symptoms of cholestasis including abdominal pain, jaundice, and fever, with peripheral eosinophilia of 10% and bone marrow eosinophilia. Liver biopsy revealed an eosinophilia infiltrate and an ERCP demonstrated bile duct...

  • Ursodeoxycholic Therapy in Chronic Liver Disease: A Meta-Analysis in Primary Biliary Cirrhosis and in Chronic Hepatitis. Simko, Vlado; Michael, Shoukry; Prego, Veronica // American Journal of Gastroenterology;Mar1994, Vol. 89 Issue 3, p392 

    Objectives: to determine whether ursodeoxycholic acid (UDCA) is effective in improving primary biliary cirrhosis (PBC) or chronic hepatitis (CH). Methods: Meta-analysis (MA) was performed on nine papers and three abstracts describing PBC and on nine papers and two abstracts with CH that were...

  • Ursocholic Acid, a Hydrophilic Bile Acid, Fails to Improve Liver Function Parameters in Primary Biliary Cirrhosis: Comparison with Ursodeoxycholic Acid. Batta, Ashok K.; Salen, Gerald; Abroon, John // American Journal of Gastroenterology (Springer Nature);Jun1997, Vol. 92 Issue 6, p1035 

    Objective: To compare the effect of short term feeding of ursocholic acid, a hydrophilic bile acid, as the unconjugated acid and the taurine conjugate, on clinical and biochemical features and bile acid metabolism with that of ursodeoxycholic acid in four patients with primary biliary cirrhosis....

  • Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. Charatcharoenwitthaya, Phunchai; Talwalkar, Jayant A.; Angulo, Paul; Gossard, Andrea A.; Keach, Jill C.; Petz, Janice L.; Jorgensen, Roberta A.; Lindor, Keith D. // Digestive Diseases & Sciences;Feb2010, Vol. 55 Issue 2, p476 

    Blockade of angiotensin II synthesis attenuates hepatic fibrosis in different experimental models of chronic liver injury. We evaluated the safety and efficacy of moexipril, an angiotensin-converting enzyme inhibitor, in patients with primary biliary cirrhosis (PBC) who have had a suboptimal...

  • Advances in treatment of primary biliary cirrhosis. QIN Hua; BAI Shishan // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;sep2013, Vol. 29 Issue 9, following p719 

    Primary biliary cirrhosis (PBC) is a chronic progressive intrahepatic cholestatic disease of unknown cause, and its incidence is increasing year by year. The main therapies for PBC include ursodeoxycholic acid for cholestasis, glucocorticoid or immunosuppressant for abnormal immune response, and...

  • Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis. Azemoto, Nobuaki; Abe, Masanori; Murata, Yosuke; Hiasa, Yoichi; Hamada, Maho; Matsuura, Bunzo; Onji, Morikazu // Journal of Gastroenterology;2009, Vol. 44 Issue 6, p630 

    Among patients with asymptomatic primary biliary cirrhosis (a-PBC), a substantial portion ultimately develop symptoms suggestive of liver injury. Prognostic variables to distinguish patients likely to become symptomatic from patients who will remain asymptomatic need to be identified. We...

  • Ursodeoxycholic Acid and Long-Term Survival in Primary Biliary Cirrhosis. Levy, Cynthia // American Journal of Gastroenterology;Feb2004, Vol. 99 Issue 2, p269 

    Comments on issues about the potential therapeutic value of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Use of orthotopic liver transplantation (OLT) to cure PBC; Investigation on the extent of benefit of UDCA therapy with or without OLT; Significance of the study on the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics